Dr James Hobkirk
SOCS VASC - Stabilising suppressor of cytokine signalling 3 (SOCS3) to limit vascular re-modelling in vein graft failure and in-stent restenosis
Status | Project Complete |
---|---|
Value | £39,323.00 |
Project Dates | Dec 1, 2019 - May 31, 2022 |
Partner Organisations | No Partners |
You might also like
Digital delivery of lifestyle behaviour change in patients requiring cardiac surgery? A scoping exercise focusing on patients and healthcare professionals Sep 12, 2022 - Jan 24, 2024
Patients who have undergone coronary artery bypass graft (CABG) benefit from cardiac rehabilitation (Class 1, Level A evidence). CR is recommended by the WHO, NICE and the NHS. Pre and post operative lifestyle was a high priority, as independently ju...
Read More about Digital delivery of lifestyle behaviour change in patients requiring cardiac surgery? A scoping exercise focusing on patients and healthcare professionals.
PreclinHUPET2: Enabling Enhanced Preclinical Nuclear Imaging For The North Of England Feb 1, 2023 - Jan 31, 2024
The grant application is to upgrade the preclinical scanning facilities for nuclear imaging of small animals (mice and rats) at the University of Hull. These facilities are used for research into disease and human health. The main areas that will be...
Read More about PreclinHUPET2: Enabling Enhanced Preclinical Nuclear Imaging For The North Of England.
FHS KE Pump Primer Award Mar 1, 2022 - Jul 31, 2022
Wolfson Equipment bid 2023 - Confocal Imaging ZEISS Elyra 7 with Lattice SIM² Oct 1, 2024 - Sep 30, 2029